Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-09 · accession 0001127602-22-027408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-13 | 2022-12-09+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $1.84 | -196.2K | 19.42M | -1% | -$360.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-12-09 | S | D | 97,554 | $1.84 | 19,513,674 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-12-12 | S | D | 98,606 | $1.84 | 19,415,068 | D | — | — |